Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas.

Standard

Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas. / Poussin, K; Dienes, H; Sirma, Hüseyin; Urban, S; Beaugrand, M; Franco, D; Schirmacher, P; Bréchot, C; Paterlini Bréchot, P.

In: INT J CANCER, Vol. 80, No. 4, 4, 1999, p. 497-505.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Poussin, K, Dienes, H, Sirma, H, Urban, S, Beaugrand, M, Franco, D, Schirmacher, P, Bréchot, C & Paterlini Bréchot, P 1999, 'Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas.', INT J CANCER, vol. 80, no. 4, 4, pp. 497-505. <http://www.ncbi.nlm.nih.gov/pubmed/9935147?dopt=Citation>

APA

Poussin, K., Dienes, H., Sirma, H., Urban, S., Beaugrand, M., Franco, D., Schirmacher, P., Bréchot, C., & Paterlini Bréchot, P. (1999). Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas. INT J CANCER, 80(4), 497-505. [4]. http://www.ncbi.nlm.nih.gov/pubmed/9935147?dopt=Citation

Vancouver

Poussin K, Dienes H, Sirma H, Urban S, Beaugrand M, Franco D et al. Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas. INT J CANCER. 1999;80(4):497-505. 4.

Bibtex

@article{22d8d77b71874959ba1b862a876b0091,
title = "Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas.",
abstract = "To explore the role of hepatitis B virus (HBV) X protein in liver carcinogenesis, independently from its role in viral replication, we have analyzed X gene structure and expression in tumorous and non-tumorous tissues obtained from 9 hepatitis B surface antigen (HBsAg)-negative, HBV DNA-positive patients. HBV replication was undetectable in tumorous tissues. HBV X gene was truncated at its 3' end in 5 of 9 tumorous tissues and 1 of 8 non-tumorous livers. Sequence analysis performed on uninterrupted X genes from 3 tumors and 3 surrounding non-tumorous tissues showed a high rate of mutations, selectively in the tumorous livers. In 1 of the 3 tumors, a frameshift mutation induced a new stop at codon 129. HBV RNAs were tested by reverse transcriptase-polymerase chain reaction (RT-PCR) with surface (S), core (C) and X specific primers. X, but not S and C, RNA expression was found in 6 of 8 tumors and in 6 of 7 non-tumorous tissues. This finding was consistent with immunohistochemical detection of X, but not S and C, antigens in all tumors also expressing X RNA. Our results provide evidence for selective expression of HBV X, but not S and C, RNA and protein in the tumorous and non-tumorous tissue of HBsAg-negative, HBV DNA-positive patients. It also shows that the structure of the X gene is modified (interrupted or highly mutated) in the majority of tumorous livers. Taken together, our findings are consistent with a potential role of mutated X proteins in HBV-related liver oncogenesis.",
author = "K Poussin and H Dienes and H{\"u}seyin Sirma and S Urban and M Beaugrand and D Franco and P Schirmacher and C Br{\'e}chot and {Paterlini Br{\'e}chot}, P",
year = "1999",
language = "Deutsch",
volume = "80",
pages = "497--505",
journal = "INT J CANCER",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas.

AU - Poussin, K

AU - Dienes, H

AU - Sirma, Hüseyin

AU - Urban, S

AU - Beaugrand, M

AU - Franco, D

AU - Schirmacher, P

AU - Bréchot, C

AU - Paterlini Bréchot, P

PY - 1999

Y1 - 1999

N2 - To explore the role of hepatitis B virus (HBV) X protein in liver carcinogenesis, independently from its role in viral replication, we have analyzed X gene structure and expression in tumorous and non-tumorous tissues obtained from 9 hepatitis B surface antigen (HBsAg)-negative, HBV DNA-positive patients. HBV replication was undetectable in tumorous tissues. HBV X gene was truncated at its 3' end in 5 of 9 tumorous tissues and 1 of 8 non-tumorous livers. Sequence analysis performed on uninterrupted X genes from 3 tumors and 3 surrounding non-tumorous tissues showed a high rate of mutations, selectively in the tumorous livers. In 1 of the 3 tumors, a frameshift mutation induced a new stop at codon 129. HBV RNAs were tested by reverse transcriptase-polymerase chain reaction (RT-PCR) with surface (S), core (C) and X specific primers. X, but not S and C, RNA expression was found in 6 of 8 tumors and in 6 of 7 non-tumorous tissues. This finding was consistent with immunohistochemical detection of X, but not S and C, antigens in all tumors also expressing X RNA. Our results provide evidence for selective expression of HBV X, but not S and C, RNA and protein in the tumorous and non-tumorous tissue of HBsAg-negative, HBV DNA-positive patients. It also shows that the structure of the X gene is modified (interrupted or highly mutated) in the majority of tumorous livers. Taken together, our findings are consistent with a potential role of mutated X proteins in HBV-related liver oncogenesis.

AB - To explore the role of hepatitis B virus (HBV) X protein in liver carcinogenesis, independently from its role in viral replication, we have analyzed X gene structure and expression in tumorous and non-tumorous tissues obtained from 9 hepatitis B surface antigen (HBsAg)-negative, HBV DNA-positive patients. HBV replication was undetectable in tumorous tissues. HBV X gene was truncated at its 3' end in 5 of 9 tumorous tissues and 1 of 8 non-tumorous livers. Sequence analysis performed on uninterrupted X genes from 3 tumors and 3 surrounding non-tumorous tissues showed a high rate of mutations, selectively in the tumorous livers. In 1 of the 3 tumors, a frameshift mutation induced a new stop at codon 129. HBV RNAs were tested by reverse transcriptase-polymerase chain reaction (RT-PCR) with surface (S), core (C) and X specific primers. X, but not S and C, RNA expression was found in 6 of 8 tumors and in 6 of 7 non-tumorous tissues. This finding was consistent with immunohistochemical detection of X, but not S and C, antigens in all tumors also expressing X RNA. Our results provide evidence for selective expression of HBV X, but not S and C, RNA and protein in the tumorous and non-tumorous tissue of HBsAg-negative, HBV DNA-positive patients. It also shows that the structure of the X gene is modified (interrupted or highly mutated) in the majority of tumorous livers. Taken together, our findings are consistent with a potential role of mutated X proteins in HBV-related liver oncogenesis.

M3 - SCORING: Zeitschriftenaufsatz

VL - 80

SP - 497

EP - 505

JO - INT J CANCER

JF - INT J CANCER

SN - 0020-7136

IS - 4

M1 - 4

ER -